Greenberg Traurig Advises Ono Pharmaceutical on Closing of Tender Offer to Acquire Deciphera Pharmaceuticals for $2.4B
June 14, 2024
June 14, 2024
NEW YORK, June 14 -- Greenberg Traurig, a law firm, issued the following news release:
Global law firm Greenberg Traurig, LLP advised Ono Pharmaceutical Co., Ltd., a Japanese company (kabushiki kaisha), on the completion of the tender offer announced April 30 to acquire all outstanding shares of common stock of U.S. biopharmaceutical company Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) for $25.60 per share, with a total amount of approximately $2.4 billion, through its wholly owne . . .
Global law firm Greenberg Traurig, LLP advised Ono Pharmaceutical Co., Ltd., a Japanese company (kabushiki kaisha), on the completion of the tender offer announced April 30 to acquire all outstanding shares of common stock of U.S. biopharmaceutical company Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) for $25.60 per share, with a total amount of approximately $2.4 billion, through its wholly owne . . .